Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $468.5400 (-0.85%) ($467.2400 - $475.5800) on Wed. Aug. 16, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.87% (three month average) | RSI | 28 | Latest Price | $468.5400(-0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(43%) IVW(42%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -0.935% in a week (0% probabilities). UUP(-9%) VIXM(-7%) TLT(-6%) TIP(-2%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.935% (StdDev 1.87%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $485.64 | 5 Day Moving Average | $468.46(0.02%) | 10 Day Moving Average | $469.25(-0.15%) | 20 Day Moving Average | $485.64(-3.52%) | To recent high | -11% | To recent low | 4.9% | Market Cap | $49.679b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |